VSEE HEALTH, INC.VSEEEarnings & Financial Report
VSEE HEALTH, INC. is a US-based telehealth technology firm offering HIPAA-compliant virtual care platforms, remote consultation tools, and chronic disease management solutions. It primarily serves healthcare providers, enterprise clients and nonprofits across North America and select global markets.
VSEE Q4 FY2025 Key Financial Metrics
Revenue
$3.9M
Gross Profit
$1.8M
Operating Profit
$-3.4M
Net Profit
$-7.9M
Gross Margin
46.7%
Operating Margin
-87.6%
Net Margin
-200.0%
YoY Growth
5.1%
EPS
$-0.31
VSEE HEALTH, INC. Q4 FY2025 Financial Summary
VSEE HEALTH, INC. reported revenue of $3.9M (up 5.1% YoY) for Q4 FY2025, with a net profit of $-7.9M (down 144.7% YoY) (-200.0% margin). Cost of goods sold was $2.1M, operating expenses totaled $5.3M.
Key Financial Metrics
| Total Revenue | $3.9M |
|---|---|
| Net Profit | $-7.9M |
| Gross Margin | 46.7% |
| Operating Margin | -87.6% |
| Report Period | Q4 FY2025 |
Revenue Breakdown
VSEE HEALTH, INC. Q4 FY2025 revenue of $3.9M breaks down across 2 segments, led by Professional Services And Other Fees at $3.1M (79.0% of total).
| Segment | Revenue | % of Total |
|---|---|---|
| Professional Services And Other Fees | $3.1M | 79.0% |
| Other | $823.2K | 21.0% |
VSEE HEALTH, INC. Annual Revenue by Year
VSEE HEALTH, INC. annual revenue history includes year-by-year totals (for example, 2025 revenue was $14.6M).
VSEE HEALTH, INC. Quarterly Revenue & Net Profit History
VSEE HEALTH, INC. results over the last 8 reported quarters, including revenue, net profit and year-over-year growth.
| Quarter | Revenue | Revenue YoY | Net Profit | Net Margin |
|---|---|---|---|---|
| Q4 FY2025 | $3.9M | +5.1% | $-7.9M | -200.0% |
| Q3 FY2025 | $4.0M | +18.7% | $-289.7K | -7.3% |
| Q2 FY2025 | $3.4M | +98.1% | $-2.6M | -77.1% |
| Q1 FY2025 | $3.3M | +104.9% | $-4.0M | -119.2% |
| Q4 FY2024 | $3.7M | +151.6% | $-3.2M | -85.9% |
| Q3 FY2024 | $3.4M | +134.1% | $-53.9M | -1607.5% |
| Q2 FY2024 | $1.7M | +34.6% | $-634.1K | -37.0% |
| Q1 FY2024 | $1.6M | +2.8% | $62.8K | 3.9% |
Income Statement
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $1.6M | $1.7M | $3.4M | $3.7M | $3.3M | $3.4M | $4.0M | $3.9M |
| YoY Growth | 2.8% | 34.6% | 134.1% | 151.6% | 104.9% | 98.1% | 18.7% | 5.1% |
Balance Sheet
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Assets | $1.4M | $78.6M | $22.3M | $20.0M | $19.4M | $18.2M | $18.7M | $22.4M |
| Liabilities | $5.6M | $25.5M | $21.4M | $20.0M | $22.9M | $23.9M | $24.3M | $17.0M |
| Equity | $-13.2M | $53.1M | $933128 | $-18488 | $-3.5M | $-5.7M | $-5.6M | $5.5M |
Cash Flow
| Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
|---|---|---|---|---|---|---|---|---|
| Operating CF | $579286 | $-3.2M | $-221034 | $-3.0M | $-440493 | $-324601 | $-754538 | $-1.9M |